Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10314792 Treatment of autism with cannabidiol

Patent 10314792 was granted and assigned to Zynerba Pharmaceuticals on June, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Zynerba Pharmaceuticals
Zynerba Pharmaceuticals
0
Date Filed
December 14, 2018
0
Date of Patent
June 11, 2019
0
Patent Applicant
Zynerba Pharmaceuticals
Zynerba Pharmaceuticals
0
Patent Application Number
16220249
0
Patent Citations Received
‌
US Patent 12121617 Transdermal delivery of cannabidiol
0
‌
US Patent 11779549 Treatment of Fragile X Syndrome with cannabidiol
‌
US Patent 12016829 Pharmaceutical composition and method for treating seizure disorders
0
‌
US Patent 11458110 Treatment of Fragile X Syndrome with cannabidiol
Patent Inventor Names
Donna Gutterman
0
Marcel Bonn-Miller
0
Terri Sebree
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10314792
0
Patent Primary Examiner
‌
Michael V Meller
0

Find more entities like US Patent 10314792 Treatment of autism with cannabidiol

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.